N
Nabsys
Uses proprietary electronic nano-channel detectors to analyze long DNA molecules at high velocity
About Nabsys
Nabsys is a pioneering company in the field of genomic analysis, specializing in semiconductor-based tools that enable the examination of entire genomes in very large fragments. Operating primarily in the biotechnology and genomics markets, Nabsys serves research institutions, clinical laboratories, and pharmaceutical companies. The company's core product is its high-definition mapping instrument, which includes an electronic nanodetector chip, pre-loaded application protocols, analytical software, and all necessary reagents for comprehensive genomic analysis. Nabsys generates revenue through the sale of these instruments and associated consumables, as well as through service contracts for ongoing support and software updates. The business model focuses on providing cost-effective, accurate, and comprehensive genomic structural information, making advanced genomic research accessible to a broader range of laboratories.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2004
- Headquarters
- Providence, United States
- Employees
- 86
- Open positions
- 8
- Dealroom signal
- 92.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, DNA, Genetics and genomics, Spinout, Genome Engineering
- Technology
- Hardware, Deep Tech, Nanotech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Aug 2024 | $0 | — | Hitachi High-Technologies | ↗ |
| LATE VCOther financing | Nov 2022 | $13M | $128M | Hitachi High-Technologies | ↗ |
Growth signals
Latest recorded traffic for Nabsys is 20K monthly website visits, up 100% over the last three months. Nabsys's team grew 95.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
PJC
Slater Technology Fund- SPStata Venture Partners
Series B and later2 investors entered at this stage
- BCBay City Capital
Hitachi High-Technologies
Other known investors1 additional known investor
Brown University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nabsys on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nabsys’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.